Chemical structure:

IUPAC name:

7-[[(4S)-5,7-difluoro-3,4-dihydro-2H-chromen-4-yl]oxy]-N,N,2-trimethyl-3H-benzimidazole-5-carboxamide

CAS number:

942195-55-3

Therapy area:

Anti-ulcer

References:

IH

Status:

Under development

Mechanism of action

Tegoprazan functions as a powerful and very specific potassium-competitive acid blocker. The drug’s mechanism of action differs from that of proton-pump inhibitors since it may directly block H+/K+ ATPase in a reversible and K+ competitive manner without needing to be converted into an active state.

DISCLAIMER: PRODUCTS COVERED BY VALID & UNEXPIRED PATENTS ARE NOT OFFERED (OR) SUPPLIED FOR COMMERCIAL SCALE. THE PATENT POSITION SHOULD BE VERIFIED & LIABILITY LIES WITH THE CUSTOMER ONLY. PRODUCTS COVERED BY PATENTS ARE AVAILABLE ONLY FOR R&D USE.